Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

PHASE2TerminatedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

July 16, 2019

Study Completion Date

July 16, 2019

Conditions
Tourette Syndrome
Interventions
DRUG

Valbenazine

vesicular monoamine transporter 2 (VMAT2) inhibitor

DRUG

Placebo oral capsule

non-active dosage form

Trial Locations (49)

10036

Neurocrine Clinical Site, New York

11720

Neurocrine Clinical Site, South Setauket

22207

Neurocrine Clinical Site, Washington D.C.

22903

Neurocrine Clinical Site, Charlottesville

29141

Neurocrine Clinical Site, Charlotte

30214

Neurocrine Clinical Site, Fayetteville

30338

Neurocrine Clinical Site, Atlanta

31406

Neurocrine Clinical Site, Savannah

32308

Neurocrine Clinical Site, Tallahassee

32561

Neurocrine Clinical Site, Gulf Breeze

32803

Neurocrine Clinical Site, Orlando

33012

Neurocrine Clinical Site, Hialeah

33125

Neurocrine Clinical Site, Miami

33136

Neurocrine Clinical Site, Miami

33157

Neurocrine Clinical Site, Palmetto Bay

33161

Neurocrine Clinical Site, North Miami

33701

Neurocrine Clinical Site, St. Petersburg

34609

Neurocrine Clinical Site, Spring Hill

45040

Neurocrine Clinical Site, Mason

46617

Neurocrine Clinical Site, South Bend

48015

Neurocrine Clinical Site, Ann Arbor

48302

Neurocrine Clinical Site, Bloomfield Hills

48322

Neurocrine Clinical Site, West Bloomfield

60634

Neurocrine Clinical Site, Chicago

68526

Neurocrine Clinical Site, Lincoln

72205

Neurocrine Clinical Site, Little Rock

72758

Neurocrine Clinical Site, Rogers

73112

Neurocrine Clinical Site, Oklahoma City

75062

Neurocrine Clinical Site, Irving

75115

Neurocrine Clinical Site, DeSoto

75243

Neurocrine Clinical Site, Dallas

77030

Neurocrine Clinical Site, Houston

77058

Neurocrine Clinical Site, Houston

78249

Neurocrine Clinical Site, San Antonio

81003

Neurocrine Clinical Site, Pueblo

85351

Neuricrine Clinical Site, Sun City

92108

Neurocrine Clinical Site, San Diego

92705

Neurocrine Clinical Site, Santa Ana

92805

Neurocrine Clinical Site, Anaheim

92835

Neurocrine Clinical Site, Fullerton

98011

Neurocrine Clinical Site, Bothell

98201

Neurocrine Clinical Site, Everett

99202

Neurocrine Clinical Site, Spokane

06905

Neurocrine Clinical Site, Stamford

02114

Neurocrine Clinical Site, Boston

03060

Neurocrine Clinical Site, Nashua

08002

Neurocrine Clinical Site, Cherry Hill

07856

Neurocrine Clinical Site, Mount Arlington

00926

Neurocrine Clinical Site, San Juan

Sponsors
All Listed Sponsors
lead

Neurocrine Biosciences

INDUSTRY